Mr Mills joins Qualitest Pharma from Columbia Laboratories, where he was CEO and president. He previously held senior management positions at Watson Pharmaceuticals, Schein Pharmaceuticals and Alpharma.
Marvin Samson, chairman and CEO of Qualitest Pharma, said: “Bob’s talents and experience as a leader and in building businesses. I have known Bob for many years and we have worked together in the past. We are very pleased that he has become a member of the Qualitest team.”
Mr Mills said: “With an excellent management team and a strong commitment to all of our stakeholders – investors, employees, customers and suppliers – I see in Qualitest tremendous potential for growth. I am excited about pursuing opportunities for success both today and in the future.”